Low molecular weight heparin and prevention of postoperative thrombosis in abdominal surgery. 1992

K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
Department of Nuclear Medicine, Universitätsklinikum Steglitz, Berlin, Germany.

In a prospective, double-blind, randomized multicenter trial the efficacy and safety of low molecular weight heparin and unfractionated heparin were compared for the prevention of postoperative deep vein thrombosis in patients undergoing abdominal surgery. Six hundred and seventy-three patients were randomly allocated to the two prophylaxis groups; 20 of these, however, did not undergo surgery and did not receive any prophylaxis. Of the remaining 653 patients 323 received one subcutaneous injection of 3,000 anti-Xa units of low molecular weight heparin and 330 received subcutaneously 5,000 U heparin three times a day. Treatment was initiated 2 h preoperatively and continued for 7 to 10 days. The occurrence of DVT was determined by the 125I-labelled fibrinogen uptake test and phlebography. Venous thrombosis was diagnosed in 24 of 323 patients (7.4%) treated with low molecular weight heparin and in 26 of 330 patients (7.9%) treated with low-dose heparin. DVT of proximal veins was detected in four patients of the low molecular weight heparin group and in three patients of the low-dose heparin group. During the observation period three pulmonary emboli - one fatal and two non-fatal - occurred in patients receiving prophylaxis with low-dose heparin. No pulmonary embolism was found in patients treated with low molecular weight heparin. Both prophylactic schemes were well tolerated. Intra- and postoperative blood loss, incidence of wound hematoma, frequency and volume of intra- and postoperative blood transfusion were similar in both groups with a slight advantage for the low molecular weight heparin group.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007813 Laparotomy Incision into the side of the abdomen between the ribs and pelvis. Minilaparotomy,Laparotomies,Minilaparotomies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006495 Heparin, Low-Molecular-Weight Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of hemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism. LMWH,Low-Molecular-Weight Heparin,Low Molecular Weight Heparin,Heparin, Low Molecular Weight
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
February 1982, British medical journal (Clinical research ed.),
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
February 1988, The British journal of surgery,
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
July 1987, Medizinische Monatsschrift fur Pharmazeuten,
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
September 2005, Current opinion in pulmonary medicine,
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
October 1992, BMJ (Clinical research ed.),
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
January 1990, Langenbecks Archiv fur Chirurgie. Supplement II, Verhandlungen der Deutschen Gesellschaft fur Chirurgie. Deutsche Gesellschaft fur Chirurgie. Kongress,
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
May 1989, The British journal of surgery,
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
December 1989, Wiener medizinische Wochenschrift (1946),
K Koppenhagen, and J Adolf, and M Matthes, and E Tröster, and J D Roder, and S Hass, and H M Fritsche, and H Wolf
January 1995, Zentralblatt fur Gynakologie,
Copied contents to your clipboard!